
Director · AgomAb Therapeutics NV · Common shares
Open-market purchase
$35K reported value · 14.3% of prior position
Disclosed 1 business day after execution (deadline: 2)
2 prior trades recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 29 | Epstein David RDirector | Open-market purchase | BUY | $35K 5,000 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 33 | Epstein David RDirector | Open-market purchase | BUY | $34K 5,000 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 37 | Epstein David RDirector | Open-market purchase | BUY | $44K 5,000 sh | Oct 22, 2026 traded Oct 21, 2026 | |
| 37 | Epstein David RDirector | Open-market purchase | BUY | $45K 5,000 sh | Oct 22, 2026 traded Oct 21, 2026 | |
| 38 | Knotnerus Tim JasperDirector, Chief Executive Officer | Open-market purchase | BUY | $44K 5,000 sh | Oct 7, 2026 traded Oct 6, 2026 | |
| 46 | Kemula Pierre Thadee VictorChief Financial Officer | Open-market purchase | BUY | $26K 3,000 sh | Oct 7, 2026 traded Oct 6, 2026 | |
| 46 | Kemula Pierre Thadee VictorChief Financial Officer | Open-market purchase | BUY | $43K 5,000 sh | Oct 7, 2026 traded Oct 6, 2026 | |
| 49 | Knotnerus Tim JasperDirector, Chief Executive Officer | Open-market purchase | BUY | $51K 6,000 sh | Oct 7, 2026 traded Oct 5, 2026 | |
| 42 | Kemula Pierre Thadee VictorChief Financial Officer | Open-market purchase | BUY | $17K 2,000 sh | Oct 7, 2026 traded Oct 6, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $34,900
Epstein David R filed this Form 4 reporting a open-market purchase of AGMB on Nov 5, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.